| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $97.7M | +19.7% |
| R&D Expense | $73.4M | +68.9% |
| SG&A Expense | $156.6M | +100.9% |
| Operating Income | -$175.8M | -139.8% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$109.9M | -25.6% |
| Income Tax | -$717K | -1986.8% |
| Net Income | -$109.2M | -24.7% |
| EPS (Basic) | -$0.59 | +7.8% |
| EPS (Diluted) | -$0.59 | +7.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $421.8M | -4.0% |
| Accounts Receivable | $17.0M | -0.4% |
| Inventory | $13.9M | +23.9% |
| Current Assets | $581.7M | -15.9% |
| Total Assets | $647.4M | -8.3% |
| Current Liabilities | $43.3M | +48.0% |
| Total Liabilities | $84.8M | -9.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.7M | -172.3% |
| Capital Expenditures | $5.2M | -22.5% |
| Investing Cash Flow | $82.5M | +144.5% |
| Financing Cash Flow | $5.2M | -99.0% |
| Free Cash Flow | -$105.9M | -142.3% |
| Stockholders' Equity |
| $562.6M |
| -8.1% |